Sunitinib Malate 37.5 mg/1 (Sunitinib Malate CAPSULE) 37.5 mg/1

Sunitinib Malate 37.5 mg capsules are a medication used for targeted therapy. This oral treatment is designed to inhibit specific proteins involved in cancer cell growth.

Strength

37.5 mg/1

Pack Size

28 CAPSULE in 1 BOTTLE (0093-8229-28)

Manufacturer / TM Owner

Teva Pharmaceuticals USA, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sunitinib Malate is primarily used in the treatment of certain types of cancer. It works by targeting proteins that help cancer cells grow and spread. This medication is often prescribed for advanced or metastatic cancers, including renal cell carcinoma and gastrointestinal stromal tumors. Patients should consult their healthcare provider to understand the specific uses of Sunitinib Malate for their condition.

Side Effects

Common effects of Sunitinib Malate may include fatigue, nausea, and diarrhea. Some patients may experience skin discoloration or hand-foot syndrome, characterized by redness and swelling on the palms and soles. It is important to monitor for any unusual symptoms and report them to a healthcare professional.

Precautions & Warnings

Sunitinib Malate should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider. Patients should avoid activities that require alertness if they experience drowsiness. Regular blood tests may be necessary to monitor for potential side effects.

Avoid Interactions

Sunitinib Malate may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. It is advisable to inform healthcare providers about all medications, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy of the medication.

Frequently Asked Questions

Sunitinib Malate is used in the treatment of certain types of cancer, targeting proteins involved in cancer cell growth.

Sunitinib Malate is typically taken orally in capsule form, as prescribed by a healthcare provider.

Common side effects may include fatigue, nausea, diarrhea, and skin discoloration.

It is important to consult a healthcare provider before taking Sunitinib Malate with other medications to avoid potential interactions.

Sunitinib Malate should be stored as directed by the healthcare provider or pharmacist, typically at room temperature.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 28 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.